Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes

被引：0
|
作者：
Perez-Monteverde, A. [1 ]
Seck, T. [2 ]
Xu, L. [2 ]
Liu, G. [2 ]
Lee, M. A. [2 ]
Sisk, C. McCrary [2 ]
Williams-Herman, D. E. [2 ]
Kaufman, K. D. [2 ]
Goldstein, B. J. [2 ]
机构：
[1] Ctr Med Docente Trinidad, Caracas, Venezuela
[2] Merck Sharp & Dohme Corp, Rahway, NJ USA
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
820
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations
    Rakesh K. Sahay
    Richa Giri
    Jayashree V. Shembalkar
    Sandeep K. Gupta
    Brij Mohan
    Prakash Kurmi
    S. Ravindra Kumar
    Vinayak M. Sawardekar
    Ashutosh Mishra
    L. Sreenivasa Murthy
    Vivek V. Arya
    Abhijit R. Sonawane
    Pravin N. Soni
    Sandip K. Gofne
    Shital R. Karnawat
    Mandodari N. Rajurkar
    Piyush M. Patel
    Lalit K. Lakhwani
    Suyog C. Mehta
    Sadhna J. Joglekar
    Advances in Therapy, 2023, 40 : 3227 - 3246
  • [32] Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) A 26-week double-blind study
    Russell-Jones, David
    Cuddihy, Robert M.
    Hanefeld, Markolf
    Kumar, Ajay
    Gonzalez, Jose G.
    Chan, Melanie
    Wolka, Anne M.
    Boardman, Marilyn K.
    DIABETES CARE, 2012, 35 (02) : 252 - 258
  • [33] Rosiglitazone and metformin fixed-dose combination provides superior glycaemic control compared to metformin and rosiglitazone monotherapies, and was well tolerated in drug-naive type 2 diabetes patients
    Chou, H
    Rood, J
    Biswas, N
    Strow, L
    Krebs, J
    Parikh, S
    Huang, C
    Cobitz, AR
    DIABETOLOGIA, 2005, 48 : A278 - A279
  • [34] Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
    Raz, Itamar
    Chen, Yu
    Wu, Mei
    Hussain, Shehla
    Kaufman, Keith D.
    Amatruda, John M.
    Langdon, Ronald B.
    Stein, Peter P.
    Alba, Maria
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 537 - 550
  • [35] Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
    Perez, Alfonso
    Zhao, Zhen
    Jacks, Randal
    Spanheimer, Robert
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2915 - 2923
  • [36] Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study
    Yoon, K. H.
    Steinberg, H.
    Teng, R.
    Golm, G. T.
    Lee, M.
    O'Neill, E. A.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2012, 14 (08): : 745 - 752
  • [37] Fixed-Dose Combination of Dapagliflozin plus Sitagliptin plus Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations
    Sahay, Rakesh K.
    Giri, Richa
    Shembalkar, Jayashree V.
    Gupta, Sandeep K.
    Mohan, Brij
    Kurmi, Prakash
    Kumar, S. Ravindra
    Sawardekar, Vinayak M.
    Mishra, Ashutosh
    Murthy, L. Sreenivasa
    Arya, Vivek V.
    Sonawane, Abhijit R.
    Soni, Pravin N.
    Gofne, Sandip K.
    Karnawat, Shital R.
    Rajurkar, Mandodari N.
    Patel, Piyush M.
    Lakhwani, Lalit K.
    Mehta, Suyog C.
    Joglekar, Sadhna J.
    ADVANCES IN THERAPY, 2023, 40 (07) : 3227 - 3246
  • [38] The efficacy of pioglitazone compared to metformin in drug naive patients with type 2 diabetes
    Schernthaner, G
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    DIABETES, 2003, 52 : A455 - A455
  • [39] One year persistence of metformin monotherapy versus metformin/sitagliptin fixed dose combination
    Simonyi Gabor
    Ferenci Tamas
    ORVOSI HETILAP, 2016, 157 (16) : 618 - 622
  • [40] Efficacy and Safety of Sitagliptin Therapy Compared with Pioglitazone in Heart Failure Patients with Type 2 Diabetes
    Naka, Toshio
    Akagami, Takafumi
    Doi, Takashi
    Masuyama, Tohru
    Ohyanagi, Mitsumasa
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S188 - S188
12345